Opus Genetics, Inc. financial data

Symbol
IRD on Nasdaq
Location
Durham, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 187% % -80%
Debt-to-equity 247% % 1995%
Return On Equity -774% % -1116%
Return On Assets -171% % -200%
Operating Margin -445% % -27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68,964,208 shares 118%
Common Stock, Shares, Outstanding 64,544,096 shares 146%
Entity Public Float $38,700,000 USD -57%
Common Stock, Value, Issued $6,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 70,636,887 shares 170%
Weighted Average Number of Shares Outstanding, Diluted 70,636,887 shares 170%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $14,633,000 USD 75%
General and Administrative Expense $24,390,000 USD 72%
Operating Income (Loss) $65,175,000 USD -121%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $68,203,000 USD -151%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $68,203,000 USD -151%
Earnings Per Share, Basic -1 USD/shares -74%
Earnings Per Share, Diluted -1 USD/shares -76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $30,815,000 USD -16%
Accounts Receivable, after Allowance for Credit Loss, Current $2,916,000 USD 57%
Other Assets, Current $86,000 USD 69%
Assets, Current $35,910,000 USD -11%
Property, Plant and Equipment, Net $212,000 USD
Assets $36,122,000 USD -11%
Accounts Payable, Current $2,395,000 USD 184%
Employee-related Liabilities, Current $1,422,000 USD 247%
Accrued Liabilities, Current $8,145,000 USD 349%
Liabilities, Current $29,087,000 USD 378%
Liabilities $30,155,000 USD 395%
Retained Earnings (Accumulated Deficit) $172,066,000 USD -66%
Stockholders' Equity Attributable to Parent $5,967,000 USD -83%
Liabilities and Equity $36,122,000 USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,994,000 USD -57%
Net Cash Provided by (Used in) Financing Activities $20,465,000 USD 761%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Shares, Issued 64,544,096 shares 146%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30,815,000 USD -16%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $35,403,000 USD 76%
Deferred Tax Assets, Gross $35,430,000 USD 76%
Depreciation $23,000 USD 360%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $68,203,000 USD -151%
Property, Plant and Equipment, Gross $25,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $20,342,000 USD 59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9,985,854 shares -0.14%
Additional Paid in Capital $178,027,000 USD 29%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $27,000 USD
Share-based Payment Arrangement, Expense $3,420,000 USD 4.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%